News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
‘Start innovating like crazy’: Fast-moving genomics startup turns to R&D to navigate the pandemic
Phase Genomics, a Seattle-based life science company, that maps and analyzes genomes, is focusing its attention inward and renewing its R&D efforts during the pandemic.
Seattle Children’s Hospital and Prevencio: The Hunt to Understand COVID-19’s Connection to Kawasaki Disease
Seattle Children’s Hospital is working with blood-testing startup Prevencio to develop a blood test to detect certain proteins and blood components leading to a firm
Seattle researchers building ‘biobank’ of patients’ blood to unlock the mysteries of the new coronavirus
The Institute for Systems Biology (ISB) and Swedish Health are building a “biobank” to study COVID-19’s impact on the human body. According to Dr. Jim
Nautilus emerges with $76M to become the ‘Illumina of proteomics’
Seattle headquartered, Nautilus Biotechnology announced a $76 million series B round to fund its work analyzing and quantifying the human proteome. Nautilus Biotechnology is looking
Seattle biotech CEO keeps a watchful eye on the market for potential IPO
Kineta Inc. CEO, Shawn Iadonato recently spoke to PSBJ about laying the groundwork for an IPO. Iadonato told PSBJ’s Megan Campbell, “We’re really watching the capital markets closely.
Seattle Genetics, Astellas’ bladder cancer med Padcev blows early expectations out of the water
Seattle-based Seattle Genetics and Astellas’ new bladder cancer treatment, Pandcev exceeded sales expectations in Q1. In a note to clients, J.P. Morgan analyst, Cory Kasimov
General Motors and Ventec to deliver first batch of ventilators ahead of schedule
General Motors and Bothell-based Ventec Life Systems are participating in a joint effort to build ventilators and add to the nation’s stockpile used to care
Adaptive Biotech’s deal with Amgen influenced by belief that COVID-19 may return seasonally, like flu
Amgen plans to use Adaptive Biotech’s proprietary technology platform to develop therapies to treat the coronavirus, especially for those working on the frontlines treating patients.
Seattle Institute’s Coronavirus Treatment Study Gets Quick FDA Approval
A potentially groundbreaking novel coronavirus treatment being explored by Seattle’s Infectious Disease Research Institute has received FDA approval to start human trials. Dr. Corey Casper, the Institute’s
Microsoft and Adaptive Biotechnologies are studying how the human immune system reacts to the coronavirus
Microsoft and Adaptive Biotechnologies are spearheading an effort to understand how the human immune system responds to the coronavirus, and why some people become so
Why Washington Is The Best State In America
U.S. News & World Report named Washington as the best state to live in America base on healthcare (ranked No. 4), education (ranked No. 4), economy